Turn Therapeutics TTRX
NASDAQ TTRX
$13.31 -1.08 (-7.51%)
At close: Oct 1, 2026 · 4:00 PM EDT

Turn Therapeutics (TTRX) Non-Current Deffered Revenue (2024 - 2026)

Updated

Turn Therapeutics (TTRX) recorded Non-Current Deffered Revenue of $1.44 million in Q2 2026, unchanged from the prior quarter.

Analysis

Turn Therapeutics (TTRX) Non-Current Deffered Revenue (2024 - 2026) Analysis & Trends

Starting with Q4 2024, Turn Therapeutics' Non-Current Deffered Revenue history includes 5 quarters.

  • Across earlier years, Non-Current Deffered Revenue came in at $1.44 million in FY2024.
  • Per Business Quant, the preceding three quarters came in at $1.44 million (Q1 2026), $1.44 million (Q4 2025) and $1.44 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Turn Therapeutics 428.65 Mn 428.65 Mn - 1.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.44 Mn
Mar 31, 2026 1.44 Mn
Dec 31, 2025 1.44 Mn
Sep 30, 2025 1.44 Mn
Dec 31, 2024 1.44 Mn
API Access

Turn Therapeutics Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TTRX&period=max&api_key=YOUR_API_KEY